Osta Therapeutics, a biotechnology company developing smart drugs to fight antibiotic resistance, today announced the appointments of Dr. Gilles Courtemanche as Senior Scientific Advisor and Dr.

A recent study by a team from Chiba University has demonstrated a promising approach for fighting antibiotic resistance by identifying a compound, V-161, that inhibits a sodium-pumping enzyme critical ...

V-161, a novel compound targeting the Na+ -V-ATPase enzyme in vancomycin-resistant Enterococcus faecium (VRE), significantly reduces bacterial growth and colonization.

Repurposing current drugs to tackle dementia is an ‘urgent priority’, academics say, but other experts warn more work is ...

Many antibiotic labels contain warnings not to take them with alcohol. Learn more about the risks of drinking while taking ...

One clone was resistant to all three antibiotic classes in a secondary screen ... remote locations with no known exposure to antibiotic drugs. The resistance proteins had low similarity to ...

A new study from Pennsylvania State University finds that household dogs can be a little-known contributor to the spread of ...

For years, Radha Lama bought antibiotics in bulk at a clinic near her home in Kathmandu, Nepal. She took the pills whenever she had a stomachache or headache, without talking to a doctor or nurse, ...